Allogeneic Segment Held Largest Share of Europe Cell therapy Market in 2019

According to our new market research study on “Europe Cell therapy Market to 2027 – Regional Analysis and Forecast – by therapy type, product, technology, application, end user,” the market is expected to reach US$ 3,610.7 million by 2027 from US$ 2,125.7 million in 2019; it is anticipated to grow at a CAGR of 6.9% during 2019–2027. The report provides trends prevailing in the Europe cell therapy market, and drivers and restraints pertaining to the market growth.

The Europe cell therapy market based on therapy type is segmented into allogeneic, and autologous. In 2019, the allogeneic segment accounted for the highest share owing to the availability of substantial number of approved products for clinical use. For instance, in 2018, Alofisel developed by TiGenix (Takeda) is the first allogeneic stem cell-based therapy approved for use in Europe. However, the autologous segment is likely register the highest CAGR in the market during the forecast period.

The growth of the Europe cell therapy market is mainly attributed to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and increasing number of approvals for cell-based therapies. However, high cost of cell therapy manufacturing is the major factor hindering the market growth in Europe.

A few of the leading companies operating in the Europe cell therapy market are Vericel Corporation, MEDIPOST, NuVasive, Inc., Mesoblast Limited, Smith & Nephew, Bristol-Myers Squibb Company, Cells for Cells, Stemedica Cell Technologies, Inc.. and others.

Europe Cell therapy Market, by Country, 2019 (%)

The report segments Europe cell therapy market as follows:

Europe Cell therapy Market – By Therapy Type

• Allogeneic
• Autologous

Europe Cell therapy Market – By Product

• Consumables
• Equipment
• Systems and Software

Europe Cell therapy Market – By Technology

• Viral Vector Technology
• Genome Editing Technology
• Somatic Cell Technology
• Cell Immortalization Technology
• Cell Plasticity Technology
• Three-Dimensional Technology

Europe Cell therapy Market – By Application

• Oncology
• Cardiovascular
• Orthopedic
• Wound Management
• Other Applications 

Europe Cell therapy Market – By End User

• Research Institutes
• Hospitals
• Others

Europe Cell therapy Market – By Country

• Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain